Andres Y. Maldonado
Stock Analyst at HC Wainwright & Co.
(4.25)
# 431
Out of 5,090 analysts
22
Total ratings
57.14%
Success rate
18.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.56 | +313.67% | 2 | Dec 3, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $25 | $7.94 | +214.86% | 1 | Nov 24, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $10 → $7 | $1.09 | +542.20% | 1 | Nov 13, 2025 | |
| TERN Terns Pharmaceuticals | Upgrades: Buy | $20 | $29.38 | -31.93% | 1 | Nov 4, 2025 | |
| SNDX Syndax Pharmaceuticals | Reiterates: Buy | $40 | $20.27 | +97.38% | 2 | Oct 27, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $40 | $10.31 | +287.97% | 2 | Oct 20, 2025 | |
| MRUS Merus | Downgrades: Neutral | $135 → $97 | $96.15 | +0.88% | 1 | Sep 30, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $23 | $5.31 | +333.15% | 1 | Sep 29, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $70 → $105 | $81.25 | +29.23% | 2 | Sep 29, 2025 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $50 → $44 | $45.12 | -2.48% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $43.29 | +73.25% | 3 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $8.04 | +210.95% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.30 | +247.83% | 1 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $6.41 | +243.48% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $21.59 | -7.36% | 1 | Aug 8, 2025 |
Protara Therapeutics
Dec 3, 2025
Reiterates: Buy
Price Target: $23
Current: $5.56
Upside: +313.67%
Day One Biopharmaceuticals
Nov 24, 2025
Reiterates: Buy
Price Target: $25
Current: $7.94
Upside: +214.86%
TScan Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $10 → $7
Current: $1.09
Upside: +542.20%
Terns Pharmaceuticals
Nov 4, 2025
Upgrades: Buy
Price Target: $20
Current: $29.38
Upside: -31.93%
Syndax Pharmaceuticals
Oct 27, 2025
Reiterates: Buy
Price Target: $40
Current: $20.27
Upside: +97.38%
Corbus Pharmaceuticals Holdings
Oct 20, 2025
Reiterates: Buy
Price Target: $40
Current: $10.31
Upside: +287.97%
Merus
Sep 30, 2025
Downgrades: Neutral
Price Target: $135 → $97
Current: $96.15
Upside: +0.88%
Candel Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $23
Current: $5.31
Upside: +333.15%
Monopar Therapeutics
Sep 29, 2025
Maintains: Buy
Price Target: $70 → $105
Current: $81.25
Upside: +29.23%
Scholar Rock Holding
Sep 23, 2025
Maintains: Buy
Price Target: $50 → $44
Current: $45.12
Upside: -2.48%
Sep 15, 2025
Reiterates: Buy
Price Target: $75
Current: $43.29
Upside: +73.25%
Sep 12, 2025
Reiterates: Buy
Price Target: $25
Current: $8.04
Upside: +210.95%
Sep 10, 2025
Reiterates: Buy
Price Target: $8
Current: $2.30
Upside: +247.83%
Aug 13, 2025
Reiterates: Buy
Price Target: $22
Current: $6.41
Upside: +243.48%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $20
Current: $21.59
Upside: -7.36%